Patrick G. Gattari is a partner with with McDonnell Boehnen Hulbert & Berghoff LLP. Mr. Gattari's practice includes patent procurement, technology transactions, and client counseling in relation to patent enforcement with emphasis in the chemical, pharmaceutical, diagnostic, and biotechnology arts. His practice focuses on counseling clients with respect to patent portfolio management and the development, licensing, acquisition, and sale of intellectual property and technology. His work includes the structuring and negotiation of technology related transactions including collaboration, joint development, consulting and outsourcing agreements, and technology assignments and licenses. He also counsels clients on the intellectual property components of mergers, acquisitions, and venture capital related transactions.
Prior to joining MBHB, Mr. Gattari was patent counsel at Dade Behring, Inc. (now Siemens Healthcare Diagnostics), where his work emphasized patent prosecution and technology transactions. He also worked for Abbott Laboratories in a variety of positions focusing on the development and production of pharmaceuticals and diagnostic devices.
Published Articles
"Supreme Court Weighs Patent Rights and Activities Associated With FDA Approval of New Drugs," BioExecutive International, April 2005.
"Determining Inventorship of U.S. Patent Applications" Intellectual Property & Technology Law Journal, Vol. 17, No. 5, 2005.